FDA gives green light to America Stem Cell transplant trial

09/5/2013 | American City Business Journals

The FDA has granted America Stem Cell approval to conduct a Phase I/IIa multicenter dual umbilical cord transplantation study. The nationwide trial will assess the efficacy of the firm's investigational therapy ASC-101 in patients with hematologic malignancies and myelodysplastic syndrome.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Technical Assistance Associate (8156)
American Institutes for Research
Washington, DC
Senior Technical Assistance Consultant
American Institutes for Research
Washington, DC
Technical Assistance Consultant
American Institutes for Research
Washington, DC
Research Associate (7846)
American Institutes for Research
Washington, DC
Teacher
Saudi Aramco
Dhahran